OREX (Orexigen Therapeutics, Inc.) cooled down during Wednesday's trading day only to bounce back during after hours trading. Ivy Investment Group investors certainly benefited from such a “spot on” pick with perfect timing. That was an easy 8% gain for about a week. We should see more gains next week along with some news relating to the FDA panel review of its drug contrave.
Remember, we introduced OREX to the Seeking Alpha community a week ago and to our investors the week prior. Ivy Investment Group has repeatedly proven its competitive edge in the market place. To find out more about our exclusive investment group, go to www.theivyinvestmentgroup.com.
Ivy, Whitfield, and Associates, G.P.
Disclosure: Long OREX